Literature DB >> 19749794

Pro-proliferative FoxM1 is a target of p53-mediated repression.

A M Barsotti1, C Prives.   

Abstract

The p53 tumor suppressor protein acts as a transcription factor to modulate cellular responses to a wide variety of stresses. In this study we show that p53 is required for the downregulation of FoxM1, an essential transcription factor that regulates many G2/M-specific genes and is overexpressed in a multitude of solid tumors. After DNA damage, p53 facilitates the repression of FoxM1 mRNA, which is accompanied by a decrease in FoxM1 protein levels. In cells with reduced p53 expression, FoxM1 is upregulated after DNA damage. Nutlin, a small-molecule activator of p53, suppresses FoxM1 levels in two cell lines in which DNA damage facilitates only mild repression. Mechanistically, p53-mediated inhibition of FoxM1 is partially p21 and retinoblastoma (Rb) family dependent, although in some cases p21-independent repression of FoxM1 was also observed. The importance of FoxM1 to cell fate was indicated by the observation that G2/M arrest follows FoxM1 ablation. Finally, our results indicate a potential contribution of p53-mediated repression of FoxM1 for maintenance of a stable G2 arrest.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749794      PMCID: PMC2898139          DOI: 10.1038/onc.2009.282

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  77 in total

1.  Microarray expression profiling of p53-dependent transcriptional changes in an immortalized mouse embryo fibroblast cell line.

Authors:  Joanna K Sax; Alex Stoddard; Maureen E Murphy; Lewis Chodosh; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

2.  p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis.

Authors:  Patricia S Kho; Zhen Wang; Li Zhuang; Yuqing Li; Joon-Lin Chew; Huck-Hui Ng; Edison T Liu; Qiang Yu
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

3.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

4.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

5.  Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.

Authors:  Jeanho Yun; Hee-Don Chae; Tae-Saeng Choi; Eun-Hee Kim; Yung-Jue Bang; Jongkyeong Chung; Kyeong-Sook Choi; Roberto Mantovani; Deug Y Shin
Journal:  J Biol Chem       Date:  2003-07-11       Impact factor: 5.157

6.  Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells.

Authors:  Megan Robinson; Ping Jiang; Jenny Cui; Jun Li; Yuli Wang; Manju Swaroop; Steve Madore; Theodore S Lawrence; Yi Sun
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

7.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

Authors:  X Chen; L J Ko; L Jayaraman; C Prives
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

8.  p21/CDKN1A mediates negative regulation of transcription by p53.

Authors:  Kristina Löhr; Constanze Möritz; Ana Contente; Matthias Dobbelstein
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

9.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

Review 10.  MDM2, an introduction.

Authors:  Tomoo Iwakuma; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

View more
  76 in total

1.  p21 cooperates with DDB2 protein in suppression of ultraviolet ray-induced skin malignancies.

Authors:  Tanya Stoyanova; Nilotpal Roy; Shaumick Bhattacharjee; Dragana Kopanja; Ted Valli; Srilata Bagchi; Pradip Raychaudhuri
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

Review 2.  Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models.

Authors:  Tanya V Kalin; Vladimir Ustiyan; Vladimir V Kalinichenko
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

3.  Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.

Authors:  Vladimir Petrovic; Robert H Costa; Lester F Lau; Pradip Raychaudhuri; Angela L Tyner
Journal:  Cancer Biol Ther       Date:  2010-06-06       Impact factor: 4.742

4.  Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1.

Authors:  Mónica Alvarez-Fernández; Vincentius A Halim; Lenno Krenning; Melinda Aprelia; Shabaz Mohammed; Albert J Heck; René H Medema
Journal:  EMBO Rep       Date:  2010-04-09       Impact factor: 8.807

5.  TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation.

Authors:  Ryo Maeda; Hiroyuki Tamashiro; Kazunori Takano; Hiro Takahashi; Hidefumi Suzuki; Shinta Saito; Waka Kojima; Noritaka Adachi; Kiyoe Ura; Takeshi Endo; Taka-Aki Tamura
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

6.  In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration.

Authors:  Hua Geng; Heng-Fu Bu; Fangyi Liu; Longtao Wu; Karl Pfeifer; Pauline M Chou; Xiao Wang; Jiaren Sun; Lu Lu; Ashutosh Pandey; Marisa S Bartolomei; Isabelle G De Plaen; Peng Wang; Jindan Yu; Jiaming Qian; Xiao-Di Tan
Journal:  Gastroenterology       Date:  2018-04-03       Impact factor: 22.682

Review 7.  Forkhead box M1 transcription factor: a novel target for cancer therapy.

Authors:  Zhiwei Wang; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Cancer Treat Rev       Date:  2009-12-22       Impact factor: 12.111

8.  Rad53 downregulates mitotic gene transcription by inhibiting the transcriptional activator Ndd1.

Authors:  Ellen R Edenberg; Ajay Vashisht; Jennifer A Benanti; James Wohlschlegel; David P Toczyski
Journal:  Mol Cell Biol       Date:  2013-12-09       Impact factor: 4.272

9.  NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS.

Authors:  Mitali Chattopadhyay; Ravinder Kodela; Gabriela Santiago; Thuy Tien C Le; Niharika Nath; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-02-14       Impact factor: 5.858

10.  Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents.

Authors:  Guangan He; Xiaolei Xie; Zahid H Siddik
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-28       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.